Integer (NYSE:ITGR) Updates FY19 Earnings Guidance

Integer (NYSE:ITGR) issued an update on its FY19 earnings guidance on Thursday morning. The company provided earnings per share guidance of $4.25-4.45 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.29. The company issued revenue guidance of $1.265-1.280 billion, compared to the consensus revenue estimate of $1.28 billion.

Shares of NYSE ITGR opened at $87.53 on Thursday. Integer has a 12-month low of $67.72 and a 12-month high of $92.61. The firm has a market cap of $2.81 billion, a P/E ratio of 23.03 and a beta of 0.95. The company has a current ratio of 2.55, a quick ratio of 1.49 and a debt-to-equity ratio of 0.84. The firm has a fifty day moving average of $82.57.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, May 2nd. The medical equipment provider reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.20. The firm had revenue of $314.70 million during the quarter, compared to the consensus estimate of $302.29 million. Integer had a return on equity of 13.37% and a net margin of 14.67%. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.61 EPS. As a group, equities analysts predict that Integer will post 4.3 earnings per share for the current fiscal year.

Several equities analysts have recently commented on the stock. ValuEngine raised shares of Integer from a hold rating to a buy rating in a research report on Tuesday, June 18th. Zacks Investment Research cut shares of Integer from a strong-buy rating to a hold rating in a research report on Wednesday, April 24th. Finally, Argus reduced their price target on shares of Integer from $90.00 to $4.29 and set an average rating on the stock in a research report on Wednesday, June 5th. They noted that the move was a valuation call. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Integer presently has an average rating of Hold and a consensus target price of $72.57.

In related news, Director James F. Hinrichs purchased 3,750 shares of Integer stock in a transaction dated Thursday, May 23rd. The shares were acquired at an average price of $68.47 per share, with a total value of $256,762.50. Following the completion of the transaction, the director now owns 6,549 shares of the company’s stock, valued at approximately $448,410.03. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 2.24% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.

Featured Story: What is an Initial Public Offering (IPO)?

Earnings History and Estimates for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with's FREE daily email newsletter.